Abiopharma

PetVivo Sets Fiscal First Quarter 2026 Conference Call for Thursday, August 14, 2025 at 5:00 p.m. ET

New Form 144 - LINDE PLC Filed: 2025-08-07 AccNo: 0001959173-25-005012 Size: 4 KB

New Form 6-K - Sanofi Filed: 2025-08-07 AccNo: 0001193125-25-175232 Size: 30 KB

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

New Form 144 - THERMO FISHER SCIENTIFIC INC. Filed: 2025-08-07 AccNo: 0001959173-25-005009 Size: 5 KB

New Form SCHEDULE 13G/A - TACTILE SYSTEMS TECHNOLOGY INC Filed: 2025-08-07 AccNo: 0001011438-25-000397 Size: 12 KB

New Form SCHEDULE 13G - Chemomab Therapeutics Ltd. Filed: 2025-08-07 AccNo: 0000895421-25-000481 Size: 11 KB

New Form 6-K - GENMAB A/S Filed: 2025-08-07 AccNo: 0001434265-25-000063 Size: 6 MB

New Form SCHEDULE 13G/A - PROKIDNEY CORP. Filed: 2025-08-07 AccNo: 0000895421-25-000479 Size: 12 KB

New Form 144 - INSULET CORP Filed: 2025-08-07 AccNo: 0001959173-25-005006 Size: 5 KB

New Form 8-K - AMEDISYS INC Filed: 2025-08-07 AccNo: 0001193125-25-175190 Size: 147 KB Item 8.01: Other Events

New Form SCHEDULE 13G/A - Beam Therapeutics Inc. Filed: 2025-08-07 AccNo: 0001104659-25-075081 Size: 13 KB

Smith+Nephew PLC Notification

New Form SCHEDULE 13G - Semler Scientific, Inc. Filed: 2025-08-07 AccNo: 0000895421-25-000478 Size: 11 KB

Zealand Pharma conference call on August 14 at 2pm CET (8am ET) to present second quarter 2025 financial results